Dysregulated erythropoietin, hepcidin, and bone marrow iron metabolism contribute to interferon-induced anemia in hepatitis C

Dysregulated erythropoietin, hepcidin, and bone marrow iron metabolism contribute to interferon-induced anemia in hepatitis C

© Mary Ann Liebert, Inc.Anemia is a complication of interferon-containing hepatitis C treatments. We characterized effects of interferon-based therapy on hepcidin and erythropoietin (EPO) production, iron metabolism, hemolysis, and hematopoiesis. Standard hemopoiesis [reticulocyte hemoglobin (Hb), r...

Full description

Bibliographic Details
Main Authors: Van Rijnsoever, M., Galhenage, S., Mollison, L., Gummer, J., Trengove, R., Olynyk, John
Format: Journal Article
Published: 2016
Online Access:http://hdl.handle.net/20.500.11937/11393

Internet

http://hdl.handle.net/20.500.11937/11393

Similar Items